All nicotine/ tobacco products at market price for Smoking, Cigarette

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Smoking, Cigarette+1 More
All nicotine/ tobacco products at market price - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study how appealing new tobacco products are, how that changes with price, and what types of people are most attracted to them.

Eligible Conditions
  • Smoking, Cigarette
  • Nicotine Vaping

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 1 day

1 day
Cigarette demand
Nicotine/tobacco products substitution

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Dual cigarette/ nicotine vaping product users
1 of 2
Exclusive cigarette smokers
1 of 2
Experimental Treatment

52 Total Participants · 2 Treatment Groups

Primary Treatment: All nicotine/ tobacco products at market price · No Placebo Group · N/A

Dual cigarette/ nicotine vaping product usersExperimental Group · 7 Interventions: All nicotine/ tobacco products at market price, Nicotine vaping products at 1/2 market price, Nicotine vaping products at 2x market price, Nicotine pouch products at 1/2 market price., Nicotine pouch products at 2x market price., Heated tobacco products at 1/2 market price., Heated tobacco products at 2x market price. · Intervention Types: Other, Other, Other, Other, Other, Other, Other
Exclusive cigarette smokersExperimental Group · 7 Interventions: All nicotine/ tobacco products at market price, Nicotine vaping products at 1/2 market price, Nicotine vaping products at 2x market price, Nicotine pouch products at 1/2 market price., Nicotine pouch products at 2x market price., Heated tobacco products at 1/2 market price., Heated tobacco products at 2x market price. · Intervention Types: Other, Other, Other, Other, Other, Other, Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 day

Who is running the clinical trial?

Virginia Polytechnic Institute and State UniversityLead Sponsor
110 Previous Clinical Trials
25,719 Total Patients Enrolled
4 Trials studying Smoking, Cigarette
697 Patients Enrolled for Smoking, Cigarette
Medical University of South CarolinaOTHER
833 Previous Clinical Trials
5,373,172 Total Patients Enrolled
11 Trials studying Smoking, Cigarette
2,995 Patients Enrolled for Smoking, Cigarette
National Cancer Institute (NCI)NIH
12,990 Previous Clinical Trials
41,298,836 Total Patients Enrolled
18 Trials studying Smoking, Cigarette
12,415 Patients Enrolled for Smoking, Cigarette
Warren K Bickel, Ph.D.Principal InvestigatorFralin Biomedical Research Institute at VTC
4 Previous Clinical Trials
857 Total Patients Enrolled
2 Trials studying Smoking, Cigarette
380 Patients Enrolled for Smoking, Cigarette

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have provided informed consent.
You are at least 21 years old.
You are willing to sample NVPs, HTPs, and NPPs.
You are a current or former exclusive cigarette smoker.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 11th, 2021

Last Reviewed: October 6th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.